Table 3.
Serum levels of 6 protein biomarkers from the second group of participants
| Levels of proteins, cps | Controls | T1D | T2D | P (T1D vs controls) | P (T2D vs controls) | P (T1D vs T2D) |
|---|---|---|---|---|---|---|
| OPN | 145 ± 77 (× 102) | 268 ± 193 (× 102) | 162 ± 82 (× 102) | 1.286E-13 | .34 | 2.652E-8 |
| IL-1RA | 4131 ± 2062 | 402 ± 458 | 663 ± 889 | 1.093E-79 | 4.597E-52 | .02 |
| YKL-40 | 1351 ± 1016 (× 102) | 318 ± 548 (× 102) | 321 ± 379 (× 102) | 1.571E-55 | 3.492E-43 | .64 |
| M-CSF | 93 ± 73 | 26 ± 17 | 26 ± 19 | 6.195E-43 | 9.843E-35 | .91 |
| TRAIL | 104 ± 67 | 140 ± 68 | 141 ± 43 | 4.312E-14 | 2.634E-12 | .62 |
| SAA | 3405 ± 7847 (× 104) | 930 ± 3203 (× 104) | 1245 ± 4132 (× 104) | .03 | .08 | .82 |
Abbreviations: cps, counts per second; IL-1RA, interleukin 1 receptor antagonist; M-CSF, macrophage colony-stimulating factor 1; OPN, osteopontin; SAA, serum amyloid A1; T1D, type 1 diabetes; T2D, type 2 diabetes; TRAIL, tumor necrosis factor superfamily member 10; YKL-40, chitinase 3-like 1.